Release Date: July 15, 115 Statement Date: July 14, 115 Statement Time: 16:37:44 Company Code: 6949 Company Name: Perther Biotech - Innovation

Subject: Announcement of Change in Share Par Value to NT$0.5 and Completion of Registration Approved by the Ministry of Economic Affairs

Applicable Clause: Clause 36 Effective Date: July 14, 115

Details: 1. Date of regulatory approval for capital reduction: Not applicable 2. Date of completion of capital change registration: 07/14/115 3. Impact on financial statements (including differences in paid-in capital, outstanding shares, and impact on net asset value per share): (1) Original par value (NT$), paid-in capital, and outstanding shares: The company's original par value is NT$10 per share, with paid-in capital of NT$655,800,500 and 65,580,050 outstanding shares. Based on the audited financial report for Q1 of Year 115, the net asset value per share is NT$40.57. (2) New par value (NT$), paid-in capital, and outstanding shares: The company's new par value is NT$0.5 per share, with paid-in capital remaining at NT$655,800,500 and outstanding shares increasing to 1,311,601,000. Based on the audited financial report for Q1 of Year 115, the net asset value per share is NT$2.03. 4. Planned share exchange program: Awaiting regulatory approval and board resolution. 5. Number of listed common shares after capital reduction: Not applicable. 6. Ratio of listed common shares to total issued common shares after reduction: Not applicable. 7. Measures for low share liquidity if post-reduction listed shares are less than 60 million and below 25%: Not applicable. 8. Other disclosures: None.

FACT BOX

  • Source: PR Times
  • Category: News